{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:01:55Z","timestamp":1762459315789},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2050-6511-15-77","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:20:02Z","timestamp":1434612002000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Justin","family":"Mandala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irith","family":"De Baetselier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Deese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Lombaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrick","family":"Owino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mookho","family":"Malahleha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Manongi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lut","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,24]]},"reference":[{"issue":"Suppl 2","key":"360_CR1","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1097\/QAI.0b013e3182986f69","volume":"63","author":"JM Baeten","year":"2013","unstructured":"Baeten JM, Haberer JE, Liu AY, Sista N: Preexposure prophylaxis for HIV prevention: where have we been and where are we going?. J Acquir Immune Defic Syndr. 2013, 63 (Suppl 2): S122-S129.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"27","key":"360_CR2","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernandez T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallas EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J: Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010, 363 (27): 2587-2599. 10.1056\/NEJMoa1011205.","journal-title":"N Engl J Med"},{"issue":"9883","key":"360_CR3","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, Chiamwongpaet S, Kitisin P, Natrujirote P, Kittimunkong S, Chuachoowong R, Gvetadze RJ, McNicholl JM, Paxton LA, Curlin ME, Hendrix CW, Vanichseni S: Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013, 381 (9883): 2083-2090. 10.1016\/S0140-6736(13)61127-7.","journal-title":"Lancet"},{"issue":"8","key":"360_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3851\/IMP2492","volume":"17","author":"C Celum","year":"2012","unstructured":"Celum C, Baeten JM: Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis. Antivir Ther. 2012, 17 (8): 1483-1493. 10.3851\/IMP2492.","journal-title":"Antivir Ther"},{"issue":"5","key":"360_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, Pathak SR, Soud FA, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, Johnson JA, Malotte CK, Hendrix CW, Brooks JT: Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012, 367 (5): 423-434. 10.1056\/NEJMoa1110711.","journal-title":"N Engl J Med"},{"issue":"8","key":"360_CR6","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1086\/368314","volume":"36","author":"A Karras","year":"2003","unstructured":"Karras A, Lafaurie M, Furco A, Bourgarit A, Droz D, Sereni D, Legendre C, Martinez F, Molina JM: Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis. 2003, 36 (8): 1070-1073. 10.1086\/368314.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"360_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00126334-200403010-00007","volume":"35","author":"H Peyriere","year":"2004","unstructured":"Peyriere H, Reynes J, Rouanet I, Daniel N, de Boever CM, Mauboussin JM, Leray H, Moachon L, Vincent D, Salmon-Ceron D: Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr. 2004, 35 (3): 269-273. 10.1097\/00126334-200403010-00007.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"360_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/00002030-200401230-00035","volume":"18","author":"G Gaspar","year":"2004","unstructured":"Gaspar G, Monereo A, Garcia-Reyne A, de Guzman M: Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution. AIDS (London, England). 2004, 18 (2): 351-352. 10.1097\/00002030-200401230-00035.","journal-title":"AIDS (London, England)"},{"issue":"4","key":"360_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/aid.2008.0202","volume":"25","author":"E Kinai","year":"2009","unstructured":"Kinai E, Hanabusa H: Progressive renal tubular dysfunction associated with long-term use of tenofovir DF. AIDS Res Hum Retrovir. 2009, 25 (4): 387-394. 10.1089\/aid.2008.0202.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"360_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QAI.0b013e3181be6be2","volume":"53","author":"M Horberg","year":"2010","unstructured":"Horberg M, Tang B, Towner W, Silverberg M, Bersoff-Matcha S, Hurley L, Chang J, Blank J, Quesenberry C, Klein D: Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010, 53 (1): 62-69. 10.1097\/QAI.0b013e3181be6be2.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"360_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J, Temu L, Monedi MC, Mak'Oketch P, Makanda M, Reblin I, Makatu SE, Saylor L, Kiernan H, Kirkendale S, Wong C, Grant R, Kashuba A, Nanda K, Mandala J, Fransen K, Deese J, Crucitti T, Mastro TD, Taylor D: Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012, 367 (5): 411-422. 10.1056\/NEJMoa1202614.","journal-title":"N Engl J Med"},{"key":"360_CR12","volume-title":"The Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events","author":"NIAID, Division of AIDS","year":"2004","unstructured":"NIAID, Division of AIDS: The Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events. 2004, Bethesda, MD, USA: National Institute of Allergy and Infectious Diseases, Division of AIDS, December 28"},{"key":"360_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/QAI.0b013e3182794723","volume":"62","author":"JL Adams","year":"2013","unstructured":"Adams JL, Sykes C, Menezes P, Prince HM, Patterson KB, Fransen K, Crucitti T, De Baetselier I, Van Damme L, Kashuba AD: Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence?. J Acquir Immune Defic Syndr. 2013, 62: 260-266. 10.1097\/QAI.0b013e3182794723.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"360_CR14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/clinchem\/39.5.902","volume":"39","author":"L Berger","year":"1993","unstructured":"Berger L: Sigma diagnostics: pioneer of kits for clinical chemistry. Clin Chem. 1993, 39 (5): 902-903.","journal-title":"Clin Chem"},{"issue":"5","key":"360_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L: Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012, 367 (5): 399-410. 10.1056\/NEJMoa1108524.","journal-title":"N Engl J Med"},{"issue":"6","key":"360_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1872-034X.2007.00072.x","volume":"37","author":"G Tarantino","year":"2007","unstructured":"Tarantino G, Conca P, Basile V, Gentile A, Capone D, Polichetti G, Leo E: A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol Res. 2007, 37 (6): 410-415. 10.1111\/j.1872-034X.2007.00072.x.","journal-title":"Hepatol Res"},{"issue":"23","key":"360_CR17","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.3748\/wjg.15.2817","volume":"15","author":"G Tarantino","year":"2009","unstructured":"Tarantino G, Minno MNDD, Capone D: Durg-induced liver injury: is it somehow foreseeable?. World J Gastroenterol. 2009, 15 (23): 2817-2833. 10.3748\/wjg.15.2817.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"360_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130 (6): 461-470. 10.7326\/0003-4819-130-6-199903160-00002.","journal-title":"Ann Intern Med"},{"issue":"4","key":"360_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006, 145 (4): 247-254. 10.7326\/0003-4819-145-4-200608150-00004.","journal-title":"Ann Intern Med"},{"issue":"1","key":"360_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s10157-013-0817-5","volume":"18","author":"L Calza","year":"2013","unstructured":"Calza L, Vanino E, Magistrelli E, Salvadori C, Cascavilla A, Colangeli V, Di Bari MA, Manfredi R, Viale P: Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. Clin Exp Nephrol. 2013, 18 (1): 104-112.","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"360_CR21","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","volume":"24","author":"A Mocroft","year":"2010","unstructured":"Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD: Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS (London, England). 2010, 24 (11): 1667-1678. 10.1097\/QAD.0b013e328339fe53.","journal-title":"AIDS (London, England)"},{"issue":"4","key":"360_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1517\/14740331003627458","volume":"9","author":"S Rodriguez-Novoa","year":"2010","unstructured":"Rodriguez-Novoa S, Alvarez E, Labarga P, Soriano V: Renal toxicity associated with tenofovir use. Expert Opin Drug Saf. 2010, 9 (4): 545-559. 10.1517\/14740331003627458.","journal-title":"Expert Opin Drug Saf"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2050-6511-15-77\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T18:31:23Z","timestamp":1599157883000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/2050-6511-15-77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1186\/2050-6511-15-77","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"17 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"77"}}